Ahead of the meeting, FDA staff recommended against including all seven substances on the Section 503A Bulks List, citing limitations in the available evidence supporting safety, effectiveness, and adequate characterization for compounding
Kvetno IM et al
Common areas for injection include the abdomen, thigh, or upper arm
About this article Cite this article Babu, D., Ramanathan, P
Additional caution or monitoring may be appropriate in research settings involving: Active cancer- or tumor-related research models, where antioxidant-related pathways may influence cellular-response or treatment-response mechanisms Severe asthma or hypersensitivity-prone research models, as rare sensitivity-related observations have been reported in some experimental contexts Sulfur-sensitive research models, due to Glutathione containing a thiol (sulfur-containing) group Complex hepatic-function or detoxification-related investigations, where antioxidant modulation may influence oxidative-stress or liver-related biomarkers Research conditions, research amounts, protocol duration, administration frequency, and concurrent compounds may influence tolerability observations across experimental settings